Journals / Journal of Clinical and Experimental Investigations / 2010 / Cilt: 1 - Sayı: 3

Psöriazis tedavisinde oral çinko sülfat, oral metotreksat ve ikisinin kombinasyonunun etkinliği

Effectiveness of oral zinc sulphate, oral methotrexate and their combination in the treatment of psoriasis

Pages
143–149
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Mild adverse effects were reported in 30% of the cases on zinc sulphate treatment.Conclusion: Zinc sulphate is an effective treatment of psoriasis but the combination of zinc sulphate plus methotrexate could be more effective than zinc sulphate or methotrexate alone.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate the effectiveness of oral zinc sulphate in treatment of psoriasis alone or in combination with methotrexate.
📊
Key Findings & Data:Materials and methods: A Total of 60 patients with psoriasis vulgaris were recruited for the study during the period October 2006 to October 2007.
💡
Conclusion & Impact:Mild adverse effects were reported in 30% of the cases on zinc sulphate treatment.Conclusion: Zinc sulphate is an effective treatment of psoriasis but the combination of zinc sulphate plus methotrexate could be more effective than zinc sulphate or methotrexate alone.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To evaluate the effectiveness of oral zinc sulphate in treatment of psoriasis alone or in combination with methotrexate. Materials and methods: A Total of 60 patients with psoriasis vulgaris were recruited for the study during the period October 2006 to October 2007. The patients were divided in to three groups according to their systemic treatments, as follows: Patients in Group1 (20 patients) were treated with oral zinc sulphate, Group 2 (20 patients) were treated with zinc sulphate plus oral methotrexate and patients in Group 3 (20 patients) were treated with oral methotrexate alone. Results: There were 34 (56.7%) men and 26 (43.3%) women, with a male: female ratio 1.3:1.Their age ranged from 15-70 years with a mean of 32±11 years. Oral zinc sulphate produced a good response in about 60% of the cases; with a relapse rate amounts to 58% noticed 4 weeks after cessation of treatment. Combination of oral zinc sulphate and methotrexate induced a good response in 85% of the patients, with a relapse rate of 59 % that was noticed 4 weeks after treatment cessation. Methotrexate alone induced a good response in 70% of the patients with a relapse rate of 64%. Mild adverse effects were reported in 30% of the cases on zinc sulphate treatment.Conclusion: Zinc sulphate is an effective treatment of psoriasis but the combination of zinc sulphate plus methotrexate could be more effective than zinc sulphate or methotrexate alone.

Özet

Amaç: Bu çalışmanın amacı, oral çinko sülfatın psoriazis tedavisinde tek başına ve metotreksat ile kombine edildiğinde etkinliğini araştırmaktır.Gereç ve yöntem: Toplam 60 psöriazis vulgaris’li hasta Ekim 2006 - Ekim 2007 tarihleri arasında çalışmaya alındı. Hastalar sistemik tedavilerine göre aşağıdaki gibi üç gruba ayrıldı: Grup 1 (20 hasta) oral çinko sülfat ile tedavi edilenler; Grup 2 (20 hasta) oral çinko sülfat+ oral metotreksat ile tedavi edilenler ve Grup 3 (20 hasta) tek başına oral metotreksat ile tedavi edilenler.Bulgular: Çalışmaya 34 (%56.7) erkek ve 26 kadın (%43.3) hasta (Erkek/Kadın oranı: 1.3/1) alındı. Oral çinko sülfat alan grupta hastaların yaklaşık %60’ında iyi sonuç alındı ve bu grupta tedavi kesilmesinden 4 hafta sonra hastaların %58’inde relaps gelişti. Oral çinko sülfat+Oral metotreksat kombinasyonu hastaların %85’inde iyi sonuç verdi ve tedavi kesilmesinden dört hafta sonra bu grupta %59 oranında relaps gözlendi. Tek başına metotreksat %70 hastada iyi sonuç verdi ve bu grupta tedavi kesilmesini takiben %64 hastada relaps gelişti. Oral çinko sülfat grubunda %30 hastada hafif yan etkiler gözlendiSonuç: Çinko sülfat psöriazis tedavisinde etkilidir, ancak çinko sülfat+Metotreksat kombinasyonu tek başına çinko sülfat veya metotreksat’tan daha etkili gözükmektedir.

🔖

Cite This Article

AHMED, J. H., ABD, S. R., I.Al-HAMDI, K. (2022). Psöriazis tedavisinde oral çinko sülfat, oral metotreksat ve ikisinin kombinasyonunun etkinliği. Journal of Clinical and Experimental Investigations, Cilt: 1 - Sayı: 3, 143–149. https://ajindex.com/articles/562085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007;370:263-71
  2. Bruner CR, Feldman SR, Ventrapragada M, Fleischer AB. A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J 2003;9:2-11
  3. British Association of Dermatologists. Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow. BMJ 1991; 303:829–35
  4. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT, Griffiths CE. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005; 366:1367-74
  5. Clemmensen OJ, Siggaard-Andersen J, Worm AM, Stahl D, Frost F, Bloch I. Psoriatic arthritis treated with oral zinc sulphate. Br J Dermatol 1980; 103:411-5
  6. Verma KC, Saini AS, Dhamija SK. Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol1980; 60:337-40
  7. Ewing CI, Gibbs AC, Ashcroft C, David TJ. Failure of oral zinc supplementation in atopic eczema. Eur J Clin Nutr. 1991; 45:507-10
  8. Burrows NP, Turnbull AJ Punchard NA, Thompson RP, Jones RR. A trial of oral zinc supplementation in psoriasis. Cutis 1994;54:117-8
  9. Reich K, Mrowietz U: Treatment goals in psoriasis. J Dtsch Dermatol Ges 2007;5:566–74
  10. Gisondi P, Fantuzzi F, Malerba M, Girolomoni G. Folic acid in general medicine and dermatology. J Dermatolog Treat. 2007;18:138-46
  11. Direct colorimetric determination of zinc. Cat number 0033 kit size:2× 5ml, Roma-Italy-via Cervinara- email:giesseonline@tiscalinet
  12. Dave’s M. The Psoriasis Area and Severity Index: Internet 2003. http://www. Dave’s Psoriasis Info.com
  13. Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30:107-14
  14. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: Immunopathogenesis and Evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol 2004;151:3-15
  15. Sharquie KE, Najim RA, Farjou IB, AL- Timimi DJ. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001; 26:21-6
  16. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo controlled clinical trial. Br J Dermatol 2002;146:423-31
  17. AL-Dori WS. Oral zinc sulphate in t